E-Learning

The Santa Claus trading window ends Friday, and a negative return during the seven-day trading window could be a bad sign for 2025, a strategist said.

Rivian stock soared Friday after the electric truck maker reported better than expected vehicle sales for its quarter ending Dec. 31.

U.S. stocks were higher on Friday, but shares of alcoholic beverage makers were lower after the surgeon general announced a link to cancer.

NEW YORK (Reuters) -U.S. stocks rebounded on Friday as investors neared the end of a holiday-shortened week that also rang in a new year, which brought with it expectations of additional Federal Reserve rate cuts and looser regulatory policies from the incoming administration. A broad rally sent all three major U.S. stock indexes to a higher close, with megacap growth companies, such as Tesla and Nvidia, providing much of the muscle to the upside and putting the tech-heavy Nasdaq out front. A multi-session selloff put a dour cap on what was a banner year for the equities market, as continued momentum of artificial intelligence technology and the U.S. Federal Reserve's first policy rate cuts in three-and-a-half years helped fuel double-digit gains in 2024.

Hopes are dim for a "Santa Claus" rally after a five-session run of losses for the S&P 500.

Surgeon General Vivek Murthy's link of alcohol to cancer risks spills over into Friday's trading session.

The acquisition was controversial as some argued foreign ownership over one of America’s largest steel producers posed a threat to national security.

Popular alcohol producers had a bumpy morning as investors reacted to an advisory from the U.S. Surgeon General about alcohol and cancer.

Shares of Rezolve Ai are climbing for a second straight day after the company unveiled plans to deepen its partnerships with tech powers Microsoft and Google.

Some 32 winners will be selected in April to win a range of prizes, including free groceries for life, one year, or one month